The North America E-Pharmacy Market, estimated at USD 71.23 Bn in 2025, is expected to exhibit a CAGR of 18.3% and reach USD 230.97 Bn by 2032.
The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.
Key market players are focused on adopting inorganic growth strategies such as partnerships, which are expected to drive the North America E-pharmacy market growth during the forecast period. For instance, in May 2021, Omnicell provides innovative pharmacy and medication management solutions for healthcare professionals and health systems pursuing the autonomous pharmacy is delighted to announce a new partnership with one of the U.S.’s largest independent pharmacy chain, Well Pharmacy. This partnership highlights Omnicell’s innovative eMAR solution to more than 350 care homes across the U.S. in a bid to help reduce medication errors, improve patient safety, and operational efficiencies so that care staff can spend more time on face-to-face patient care. Through Omnicell’s eMAR solution which includes patient-specific barcode technology, care homes can significantly reduce medication error figures and improve patient safety to help ensure the right dose of the right medication is given to the right person at the right time.
North America E-pharmacy Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019, as "coronavirus disease 2019" or COVID-19. This virus spreads quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of equipment from one place to another.
COVID-19 had a positive impact on the North America E-pharmacy market. For instance, According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 14 million infected individuals worldwide as of July, 2020. The lockdown in various countries due to the COVID-19 pandemic has created an economic burden on the private healthcare sectors such as pharmaceutical industries, specialty clinics, pharmacy stores, and others. Despite such an economic slowdown in the healthcare sector, digital healthcare sectors such as e-health, e-pharmacy, and e-prescription experienced significant growth during this COVID 19 pandemic. The growth of the e-pharmacy sector is attributed to the increasing consumer preference for online buying of medicinal products from online pharmacy stores with an aim to maintain social distancing. Moreover, restricted outdoor movement except for supplying and procuring essential goods and services including medicinal products, and increasing demand for hand sanitizers and face masks have accelerated the growth of the North America e-pharmacy market.